Pediatric Nonalcoholic Fatty Liver Disease in 2009

被引:106
作者
Alisi, Anna
Manco, Melania [2 ]
Vania, Andrea [3 ,4 ]
Nobili, Valerio [1 ]
机构
[1] Bambino Gesu Childrens Hosp & Res Inst, Liver Unit, I-00165 Rome, Italy
[2] Childrens Hosp & Res Inst, Sci Directorate Bambino Gesu, Rome, Italy
[3] Univ Roma La Sapienza, Ctr Nutr & Dietet, Rome, Italy
[4] Univ Roma La Sapienza, Dept Pediat, Rome, Italy
关键词
PUBERTAL INSULIN-RESISTANCE; RANDOMIZED CONTROLLED-TRIAL; PLACEBO-CONTROLLED TRIAL; VITAMIN-E TREATMENT; OBESE CHILDREN; URSODEOXYCHOLIC ACID; METABOLIC SYNDROME; HEPATIC STEATOSIS; TRANSIENT ELASTOGRAPHY; JAPANESE CHILDREN;
D O I
10.1016/j.jpeds.2009.06.014
中图分类号
R72 [儿科学];
学科分类号
100202 [儿科学];
摘要
Over the last decade, there has been a growing recognition of NAFLD as pediatric disease. In view of the lack of longitudinal studies describing the natural history of the disease and, particularly, poor diagnostic means of distinguishing benign from progressive forms, it is important to prevent fatty liver in children and attempt to intervene as soon as it is suspected. Promoting physical activity and healthy eating early in the lives of children may decrease the risk of NAFLD. In the early preschool years, parents should be educated to include healthy food choices and active play into the lifestyles of their entire families. Obese children presenting with concurrent metabolic abnormalities merit at the very least an assay of liver enzyme and ultrasound evaluation for fatty liver. Monitoring of liver histology can be worthwhile in extremely obese children with severely impaired metabolism, because they may develop fibrosis and hepatic insufficiency as young adults. © 2009 Mosby, Inc. All rights reserved.
引用
收藏
页码:469 / 474
页数:6
相关论文
共 93 条
[1]
The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD [J].
Angulo, Paul ;
Hui, Jason M. ;
Marchesini, Giulio ;
Bugianesi, Ellisabetta ;
George, Jacob ;
Farrell, Geoffrey C. ;
Enders, Felicity ;
Saksena, Sushma ;
Burt, Alastair D. ;
Bida, John P. ;
Lindor, Keith ;
Sanderson, Schuyler O. ;
Lenzi, Marco ;
Adams, Leon A. ;
Kench, James ;
Therneau, Terry M. ;
Day, Christopher P. .
HEPATOLOGY, 2007, 45 (04) :846-854
[2]
[Anonymous], 2000, WHO TECHN REP SER
[3]
[Anonymous], 1995, PHYS STAT UINT ANT
[4]
Arslan N, 2005, TURKISH J PEDIATR, V47, P23
[5]
Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease [J].
Barshop, N. J. ;
Sirlin, C. B. ;
Schwimmer, J. B. ;
Lavine, J. E. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 28 (01) :13-24
[6]
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis [J].
Belfort, Renata ;
Harrison, Stephen A. ;
Brown, Kenneth ;
Darland, Celia ;
Finch, Joan ;
Hardies, Jean ;
Balas, Bogdan ;
Gastaldelli, Amalia ;
Tio, Fermin ;
Pulcini, Joseph ;
Berria, Rachele ;
Ma, Jennie Z. ;
Dwivedi, Sunil ;
Havranek, Russell ;
Fincke, Chris ;
DeFronzo, Ralph ;
Bannayan, George A. ;
Schenker, Steven ;
Cusi, Kenneth .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (22) :2297-2307
[7]
Bugianesi E, 2007, Clin Liver Dis, V11, P191, DOI 10.1016/j.cld.2007.02.006
[8]
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease [J].
Bugianesi, E ;
Gentilcore, E ;
Manini, R ;
Natale, S ;
Vanni, E ;
Villanova, N ;
David, E ;
Rizzetto, M ;
Marchesini, G .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (05) :1082-1090
[9]
Comparison of blood tests for liver fibrosis specific or not to NAFLD [J].
Cales, Paul ;
Laine, Fabrice ;
Boursier, Jerome ;
Deugnier, Yves ;
Moal, Valerie ;
Oberti, Frederic ;
Hunault, Gilles ;
Rousselet, Marie Christine ;
Hubert, Isabelle ;
Laafi, Jihane ;
Ducluzeaux, Pierre Henri ;
Lunel, Francoise .
JOURNAL OF HEPATOLOGY, 2009, 50 (01) :165-173
[10]
Hepatic steatosis in obese Chinese children [J].
Chan, DFY ;
Li, AM ;
Chu, WCW ;
Chan, MHM ;
Wong, EMC ;
Liu, EKH ;
Chan, IHS ;
Yin, J ;
Lam, CWK ;
Fok, TF ;
Nelson, EAS .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (10) :1257-1263